Area of research
Surgery · Molecular Biology
Research interest
Research focused on Familial hypercholesterolemia and Placebo, with related work in Adverse effect, Hyperlipidemia, Blood pressure. Notable publications include 'Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia', 'Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia', and 'PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study'.
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
Recaticimab in adult heterozygous familial hypercholesterolaemia (REMAIN-3): a multicentre, randomized, double-blind, placebo-controlled Phase 3 study
Efficacy and Safety of a Generic Clevidipine in Hypertensive Urgencies and Non‐Fulminant Hypertensive Emergencies: A Phase III, Multicenter, Randomized, Double‐Blind, Positive Drug Parallel‐Controlled Study
Recaticimab Monotherapy for Nonfamilial Hypercholesterolemia and Mixed Hyperlipemia
Recaticimab as Add-On Therapy to Statins for Nonfamilial Hypercholesterolemia
PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study